For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Zalutumumab 8 mg/kg | None | None | None | 7 | 13 | 13 | 13 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Diarrhoea | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Constipation | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Ileus | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Stomatitis | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Neutropenia | None | Blood and lymphatic system disorders | CTCAE (3.0) | View |
| Chills | None | General disorders | CTCAE (3.0) | View |
| Malaise | None | General disorders | CTCAE (3.0) | View |
| Gastroenteritis | None | Infections and infestations | CTCAE (3.0) | View |
| Viral infection | None | Infections and infestations | CTCAE (3.0) | View |
| Dehydration | None | Metabolism and nutrition disorders | CTCAE (3.0) | View |
| Respiratory failure | None | Respiratory, thoracic and mediastinal disorders | CTCAE (3.0) | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Rash | None | Skin and subcutaneous tissue disorders | CTCAE (3.0) | View |
| Constipation | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Nausea | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Fatigue | None | General disorders | CTCAE (3.0) | View |
| Dysphagia | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Alopecia | None | Skin and subcutaneous tissue disorders | CTCAE (3.0) | View |
| Cough | None | Respiratory, thoracic and mediastinal disorders | CTCAE (3.0) | View |
| Dyspnoea | None | Respiratory, thoracic and mediastinal disorders | CTCAE (3.0) | View |
| Diarrhoea | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Dyspepsia | None | Gastrointestinal disorders | CTCAE (3.0) | View |
| Anorexia | None | Metabolism and nutrition disorders | CTCAE (3.0) | View |